Современные маркеры воспалительного процесса в хирургической практике
А.М. Морозов, https://orcid.org/0000-0003-4213-5379, ammorozovv@gmail.comА.Н. Сергеев, https://orcid.org/0000-0002-9657-8063
С.В. Жуков, https://orcid.org/0000-0002-3145-9776
Н.С. Новикова, https://orcid.org/0000-0003-4564-4777
М.А. Беляк, https://orcid.org/0000-0001-6125-7676
Тверской государственный медицинский университет; 170100, Россия, Тверь, ул. Советская, д. 4
Usefulness of presepsin for the early detection of infectious complications after elective colorectal surgery, compared with C‐reactive protein and procalcitonin
Erika Amanai1, Kishiko Nakai1*, Junichi Saito2, Eiji Hashiba2, Takuya Miura3, Hajime Morohashi3, Yoshiyuki Sakamoto3, Akio Mikami4, Kenichi Hakamada3 & Kazuyoshi Hirota51 Department of Anesthesiology, Hirosaki University Hospital, 5 Zaifu-cho, Hirosaki, Aomori 036-8562, Japan.
2 Division of Intensive Care Unit, Hirosaki University Hospital, Hirosaki, Japan.
3 Department of Gastroenterological Surgery and Pediatric Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
4 Central Clinical Laboratory, Hirosaki University Hospital, Hirosaki, Japan.
5 Department of Anesthesiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
* Email: kishiko_sk1064@hirosaki-u.ac.jp
Prediction of Postoperative Sepsis Based on Changes in Presepsin Levels of Critically Ill Patients with Acute Kidney Injury after Abdominal Surgery
Chang Hwan Kim and Eun Young Kim *Division of Trauma and Surgical Critical Care, Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea;
changhwan.kim0227@gmail.com *
Correspondence: freesshs@naver.com;
Perioperative presepsin as a potential early predictor for postoperative infectious complications in cardiac surgery
Hiroto Suzuki1, Hiroto Narimatsu2, Masaki Nakane3, Mitsuaki Sadahiro4, Kaneyuki Kawamae11 Department of Anaesthesiology, Yamagata University Faculty of Medicine, Yamagata, Japan
2 Cancer Prevention and Cancer Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan 3Department of Emergency and Critical Care Medicine, Yamagata University Faculty of Medicine, Yamagata, Japan
4 Department of Cardiovascular, Thoracic and Pediatric Surgery, Yamagata University Faculty of Medicine, Yamagata, Japan
Usefulness of Presepsin for the Early Detection of Infectious Complications after Elective Colorectal Surgery, Compared with C-Reactive Protein and Procalcitonin
Erika Amanai Hirosaki University Hospital, Kishiko Nakai (kishiko_sk1064@yahoo.co.jp) https://orcid.org/0000-0002-6618-7803, Junichi Saito Hirosaki University Hospital, Eiji Hashiba Hirosaki University Hospital, Takuya Miura Hirosaki University Graduate School of Medicine, Hajime Morohashi Hirosaki University Graduate School of Medicine, Yoshiyuki Sakamoto Hirosaki University Graduate School of Medicine, Akio Mikami Hirosaki University Hospital, Kenichi Hakamada Hirosaki University Graduate School of Medicine, Kazuyoshi Hirota Hirosaki University Graduate School of Medicine.Evaluation of the Diagnostic and Prognostic Value of CSF Presepsin Levels in Patients with Postneurosurgical Ventriculitis/Meningitis
Guanghui Zheng1–3,*, Chenxi Zhang1–3,*, Guojun Zhang1–3, Chunqing Shao1–31Department of Clinical Diagnosis, Laboratory of Beijing Tiantan Hospital and Capital Medical University, Beijing, People’s Republic of China; 2NMPA Key Laboratory for Quality Control of in vitro Diagnostics, National Medical Products Administration, Beijing, People’s Republic of China; 3Beijing Engineering Research Center of Immunological Reagents Clinical Research, Beijing Municipal Science and Technology Commission, Beijing, People’s Republic of China
*These authors contributed equally to this work
Presepsin as a biomarker in perioperative medicine
Jessica HANDKE 1, Ornella PIAZZA 2 *, Jan LARMANN 1,and Surgery, University of Salerno, Baronissi, Salerno, Italy; 3Department of Surgical and Biomedical Sciences,
University of Perugia, Perugia, Italy
The novel early predictive marker presepsin for postoperative pancreatic fistula: A pilot study
Presepsin as a diagnostic marker of sepsis in children and adolescents: a systemic review and meta-analysis
College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Full list of author information is available at the end of the article
Presepsin as a biomarker in perioperative medicine
Jessica HANDKE 1, Ornella PIAZZA 2 *, Jan LARMANN 1,Simonetta TESORO 3, Edoardo DE ROBERTIS 3
University of Perugia, Perugia, Italy
Первый опыт применения селективной лпс-адсорбции в комплексной интенсивной терапии детей с грамотрицательным сепсисом после кардиохирургических операций
Ярустовский М.Б., Абрамян М.В., Солдаткина А.О., Комардина Е.В.,Назарова Е.И., Плющ М.Г., Рогальская Е.А.
ФГБУ «НМИЦ сердечно-сосудистой хирургии им. А.Н. Бакулева»
Минздрава России, 121552, Москва, Россия
The Level of Oxidative Neutrophil Response When Determining Endotoxin Activity Assay: A New Biomarker for Defining the Indications and Effectiveness of Intensive Care in Patients with Sepsis
Michael Yaroustovsky, Ekaterina Rogalskaya, Marina Plyushch,Ludmila Klimovich, Nataliya Samsonova, and Marina Abramyan
Federal State Budget Institution “Bakulev National Scientific and Practical Center for Cardiovascular Surgery” of the Ministry of Healthcare of the Russian Federation (Bakulev NSPCCS), Moscow, Russia
Диагностическое и прогностическое значение современных биохимических маркеров септических осложнений у больных после операций на сердце и сосудах
Рогальская Екатерина АнатольевнаАВТОРЕФЕРАТ
диссертации на соискание ученой степени кандидата медицинских наук
Москва – 2017
Диссертационная работа выполнена в Федеральном государственном бюджетном учреждении «Национальный научно-практический центр сердечно-сосудистой хирургии имени А.Н. Бакулева» Министерства здравоохранения Российской Федерации
Научные руководители:
Доктор медицинских наук, профессор, член-корр. РАН Ярустовский Михаил Борисович
Доктор медицинских наук, профессор Самсонова Наталия Николаевна
Presepsin and Inflammatory Markers Correlate with Non-occlusive Mesenteric Ischemia after Cardiovascular Surgery
Jonas Stroeder, MD, Homburg, Germany (Presenter) Nothing to DiscloseHeinrich Groesdonk, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Hans-Joachim Schaefers, MD, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Matthias Klingele, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Stefan Wagenpfeil, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Marcus Katoh, MD, Krefeld, Germany (Abstract Co-Author) Consultant, Straub Medical AG Consultant, Medtronic, Inc
Hagen Bomberg, Homburg, Germany (Abstract Co-Author) Nothing to Disclose
Arno Buecker, MD, Homburg, Germany (Abstract Co-Author) Research Grant, Siemens AG; Consultant, Bracco Group; Speaker,
Peter Minko, MD, Homburg, Germany (Abstract Co-Author) Speaker, Straub Medical AG Consultant,
Straub Medical AG
Применение пресепсина и прокальцитонина в диагностике сепсиса у тяжело обожженных пациентов
Жилинский Е.В.1, Алексеев С.А. 2, Жензерова И.А. 1, Блыга Е.Г. 1УЗ «Городская клиническая больница скорой медицинской помощи», Минск, Беларусь
УО «Белорусский государственный медицинский университет», Минск, Беларусь
The False Positive Soluble CD 14 Subtype is Lower Than That of Procalcitonin in Postoperative Severe Elective Surgery Patients: A Prospective Observational Trial
Yoshitaka Hara, M.D., Tomoyuki Nakamura, M.D., Naohide Kuriyama, M.D.,Satoshi Komatsu, M.D., Seiko Hayakawa, M.D., Sohta Uchiyama, M.D.,
Daisuke Niimi, M.D., Chizuru Yamashita, M.D., Junpei Shibata, M.D.,
Ph.D., Osamu Nishida, M.D.,Ph.D.
Fujita Health University School of Medicine, Toyoake, Japan
Динамика пресепсина и прокальцитонина у пациентов хирургического профиля
Кулабухов В.В., Демидова В.С., Кудрявцев А.Н., Чижов А.Г., Звягин А.А.,Терехова Р.П., Баранова А.А.
ФГБУ «Институт хирургии им. А.В.Вишневского» Минздрава России
Тезисы XII Съезда хирургов России 5-10 октября 2015 г. г. Ростов-на-Дону
Presepsin can replace procalcitonin in the prediction of sepsis In transplant patients after antithymocyte globulin administration
E. Spanuth1, B. Ivandic1, J. Wilhelm3, R. Thomae2, K. Werdan31DIAneering - Diagnostics Engineering & Research, Heidelberg, Germany
2Mitsubishi Chemical Europe, Düsseldorf, Germany
3University Clinics Halle (Saale), Department of Medicine III, Martin-Luther-University
Halle-Wittenberg, Germany
Prognostic significance of presepsin in patients with sepsis
E. Rogalskaya3, M. Plyushsh2, N. Samsonova3, M. Yaroustovsky11Department of Detoxication and Endoscopy, Bakoulev Scientific Center for Cardiovascular Surgery, Moscow
2Laboratory of Biochemistry, Clinical Laboratory Diagnostics Division, Bakoulev Scientific Center for Cardiovascular Surgery, Moscow
3Laboratory of Hematology, Clinical Laboratory Diagnostics Division, Bakoulev Scientific Center for Cardiovascular Surgery, Moscow
Пресепсин в диагностике гнойных осложнений у хирургических больных и пациентов с ожоговой травмой
Демидова В.С., Ушакова Т.А., Звягин А.А., Бобровников А.Э., Медова О.В., КоряковИ.А., Казеннов В. В., Шишкин М.Н., Баранова А.А., Самадурова Л.Л., Кучейник А.Ш.
ФГБУ «Институт хирургии им. А.В. Вишневского», Россия, Москва